VU0542270
Based on 1 Customer Validation
VU0542270 is a selective vascular Kir6.1/SUR2B KATP channel inhibitor with an IC50 value of 100 nM. VU0542270 has an IC50 > 30 μM for the other nine members of the Kir channel family. VU0542270 can be used in the study of cardiovascular disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.48%
- CAS No.: 1396814-79-1
- Formule: C14H13N3OS3
- Masse moléculaire:335.47
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
VU0542270 (0-10 μM; 0-90 min) has an inhibitory effect on Kir6.1/SUR2B and can completely inhibit KATP current[1].
VU0542270 (1 nM-100 μM; 20 min) induces contraction of isolated ductus arteriosus in pregnant mice, similar to Glibenclamide (HY-15206)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Route | Dose (mg/kg) | CLp (mL/min per kg) | t1/2 (h) | MRT (h) | VSS (L/kg) |
| i.v. | 1 | 17.7 | 0.64 | 0.19 | 0.20 |